1 Association of diabetes-related kidney disease with cardiovascular and non-cardiovascular outcomes: a retrospective cohort study.

2 Prevalence of hyperfiltration among US youth/young adults with overweight and obesity: A population-based association study.

3 Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases.

4 Urine protein-to-creatinine ratio in cattle with subclinical renal disease.

5 СТАТУС ХАТНЬОЇ РОБІТНИЦІ В УРБАНІЗОВАНОМУ СОЦІУМІ УКРАЇНИ ПЕРШОЇ ПОЛОВИНИ ХХ СТ. / homeworkers status in ukrainian urbanized society at first part of xx century

6 a study on osteoarthritis of knee joint

7 exploring sleep disorders in patients with chronic kidney disease

8 the role of genetic polymorphisms of the renin–angiotensin system in renal diseases: a meta-analysis

9 Adrenergic beta-1 receptor genetic variation predicts longitudinal rate of GFR decline in hypertensive nephrosclerosis

10 Left Ventricular Hypertrophy in Mild and Moderate Reduction in Kidney Function Determined Using Cardiac Magnetic Resonance Imaging and Cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA)

11 Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.

12 Amyloid-β deposition in basal frontotemporal cortex is associated with selective disruption of temporal mnemonic discrimination.

13 Author Correction: Hydrophobic pore gates regulate ion permeation in polycystic kidney disease 2 and 2L1 channels (Nature Communications, (2018), 9, 1, (2302), 10.1038/s41467-018-04586-x)

14 Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis

15 Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

16 Urinary Uromodulin Levels and UMOD Variants in Black South Africans with Hypertension-Attributed Chronic Kidney Disease

17 Prevalence and Predictors of Chronic Kidney Disease in a Semiurban Community in Lagos

18 Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania — a cross-sectional study

19 Study of Evidences on Chronic Kidney Disease Due to Unknown Etiology Based on Environmental, Social, Economic and Health Patterns of Selected Population: A Case Study Done at Wilgamuwa Area

20 Comparison of HbA1c levels and body mass index for prevention of diabetic kidney disease: A retrospective longitudinal study using outpatient clinical data in Japanese patients with type 2 diabetes mellitus.

21 Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease

22 Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4.

23 Determination of genotoxic effects in hemodialysis patients with chronic kidney disease and the role of diabetes mellitus and other biochemical parameters.

24 Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients

25 Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker in Diabetes with Earlier Chronic Kidney Disease Stages

26 Prevalence and Disease Burden of Chronic Kidney Disease.

27 Primary care physicians' perceptions of barriers and facilitators to management of chronic kidney disease: A mixed methods study.

28 Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of Hospitalization for New-Onset Kidney Disease: A Real-World Analysis of High-Risk Statin-Treated Patients.

29 A novel splicing mutation in the PKD1 gene causes autosomal dominant polycystic kidney disease in a Chinese family: a case report.

30 Diagnostic potential of simplified methods for measuring glomerular filtration rate to detect chronic kidney disease in dogs.

31 Optimal Blood Pressure in Patients With Coronary Artery Disease and Chronic Kidney Disease: HIJ-CREATE Substudy.

32 Metabolic acidosis in chronic kidney disease: The nutritional approach

33 Serum intact parathyroid hormone levels in cats with chronic kidney disease

34 Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status.

35 Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis

36 Using chronic kidney disease trigger tools for safety and learning: a qualitative evaluation in East London primary care.

37 Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease.

38 Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review.

39 Patient Engagement and Patient-Centred Care in the Management of Advanced Chronic Kidney Disease and Chronic Kidney Failure

40 Quest to identify geochemical risk factors associated with chronic kidney disease of unknown etiology (CKDu) in an endemic region of Sri Lanka-a multimedia laboratory analysis of biological, food, and environmental samples.

41 Drug-induced kidney diseases

42 Commentary: Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

43 Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.

44 The first step in creating national Chronic Kidney Disease (CKD) guidelines - a questionnaire

45 Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility

46 Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease.

47 Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.

48 SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.

49 Proprotein convertase subtilisin/kexin type 9 in kidney disease.

50 An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.

51 Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions.

52 Improves Chronic Kidney Disease by Affecting TLR4/NF-B Redox Signaling Pathway.

53 Evaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in Lebanon.

54 Orthostatic Hypotension in Asymptomatic Patients with Chronic Kidney Disease.

55 Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.

56 Associations between plasma lysophospholipids concentrations, chronic kidney disease and the type of renal replacement therapy.

57 Lipid Accumulation and Chronic Kidney Disease.

58 Effect of L-carnitine and conjugated linoleic acid supplements on haemoglobin levels and haptoglobin genotype in chronic kidney disease.

59 Plasma Levels of Preβ1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease.

60 On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study

61 Cardiovascular Risk and Lipid Management Reimbursement Between Patients with Stage 3–5 Chronic Kidney Disease and Those with Diabetes Mellitus

62 HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

63 Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

64 The efficiency of metabolic impact of S-adenosylmethionine and meldonium on parameters of lipid profile and insulin resistance during comorbid course of nonalcocholic steatohepatitis, obesity and chronic kidney disease stage І-ІІ

65 DYSLIPIDEMIA AS A FACTOR FOR PROGRESSION OF RENAL OSTEODYSTROPHY AND CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON PERITONEAL DIALYSIS

66 [Association of metabolic syndrome with chronic kidney disease in premenopausal and postmenopausal women].

67 A subset of low density granulocytes is associated with vascular calcification in chronic kidney disease patients.

68 Chronic Kidney Disease and the Use of Social Media as Strategy for Health Education in Brazil.

69 Renal Cancer Surgery in Patients without Preexisting Chronic Kidney Disease-Is There a Survival Benefit for Partial Nephrectomy?

70 Impact of urate-lowering drugs on the progression and recovery from chronic kidney disease among gout patients.

71 Knowledge and awareness of nonpharmacist salespersons regarding over-the-counter drug use in patients with chronic kidney disease in Japan.

72 Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease.

73 Performance-based prediction of chronic kidney disease using machine learning for high-risk cardiovascular disease patients

74 Development of an electronic health record-based chronic kidney disease registry to promote population health management

75 Progression of Tubulointerstitial Fibrosis and the Chronic Kidney Disease Phenotype – Role of Risk Factors and Epigenetics

76 Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

77 Progressive Renal Dysfunction due to IgG4-Related Kidney Disease Refractory to Steroid Therapy: A Case Report.

78 Association of serum uric acid levels with the incident of kidney disease and rapid eGFR decline in Chinese individuals with eGFR > 60 mL/min/1.73 m and negative proteinuria.

79 A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Digestive and Genitourinary System: Inflammatory Bowel Diseases, Celiac Disease, and Chronic Kidney Disease.

80 Public health interventions for chronic diseases: cost-benefit modelizations for eradicating chronic kidney disease of multifactorial origin (CKDmfo/ CKDu) from tropical countries.

81 Berberine protects against diabetic kidney disease via promoting PGC-1α-regulated mitochondrial energy homeostasis.

82 Association between severe periodontitis and chronic kidney disease severity in pre-dialytic patients: A cross-sectional study.

83 Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study

84 Metabolic Activation of Flavin Monooxygenase-mediated Trimethylamine-N-Oxide Formation in Experimental Kidney Disease

85 Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study

86 The pathobiology of polycystic kidney disease from a metabolic viewpoint

87 Higher estimated net endogenous acid production with lower intake of fruits and vegetables based on a dietary survey is associated with the progression of chronic kidney disease

88 Non-medical barriers reported by nephrologists when providing renal replacement therapy or comprehensive conservative management to end-stage kidney disease patients: a systematic review.

89 Comparison of the Hepatotoxic Potential of Two Treatments for Autosomal-Dominant Polycystic Kidney DiseaseUsing Quantitative Systems Toxicology Modeling.

90 Direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.

91 The Effect of Intermittent Hemodialysis on the Hematological and Serum Biochemistry Profile in Dogs With Chronic Kidney Disease

92 Left Ventricular Mass and Incident Chronic Kidney Disease.

93 Detecting Lifestyle Risk Factors for Chronic Kidney Disease With Comorbidities: Association Rule Mining Analysis of Web-Based Survey Data.

94 Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients.

95 Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients.

96 Corrigendum to 'Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease' EBioMedicine 47 (2019) 446-456.

97 Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins.

98 Biochemical and histopathological changes in Wistar rats after consumption of boiled and un-boiled water from high and low disease prevalent areas for chronic kidney disease of unknown etiology (CKDu) in north Central Province (NCP) and its comparison with low disease prevalent Colombo, Sri Lanka.

99 Symmetric dimethylarginine in dysfunctional high-density lipoprotein mediates endothelial glycocalyx breakdown in chronic kidney disease.

100 Refining the Mouse Subtotal Nephrectomy in Male 129S2/SV Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac Dysfunction.

101 WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.

Keyword Connections

Journals

Research Groups

Bibliographies